Similarities between Monoclonal antibody and Ofatumumab
Monoclonal antibody and Ofatumumab have 8 things in common (in Unionpedia): Alemtuzumab, Anemia, Antibody-dependent cell-mediated cytotoxicity, CD20, Complement-dependent cytotoxicity, Multiple sclerosis, Rheumatoid arthritis, Rituximab.
Alemtuzumab
Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, MabCampath and Campath-1H, and in the treatment of multiple sclerosis as Lemtrada.
Alemtuzumab and Monoclonal antibody · Alemtuzumab and Ofatumumab ·
Anemia
Anemia is a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood, or a lowered ability of the blood to carry oxygen.
Anemia and Monoclonal antibody · Anemia and Ofatumumab ·
Antibody-dependent cell-mediated cytotoxicity
The antibody-dependent cell-mediated cytotoxicity (ADCC), also referred to as antibody-dependent cellular cytotoxicity, is a mechanism of cell-mediated immune defense whereby an effector cell of the immune system actively lyses a target cell, whose membrane-surface antigens have been bound by specific antibodies.
Antibody-dependent cell-mediated cytotoxicity and Monoclonal antibody · Antibody-dependent cell-mediated cytotoxicity and Ofatumumab ·
CD20
B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R+, CD117+) and progressively increasing in concentration until maturity.
CD20 and Monoclonal antibody · CD20 and Ofatumumab ·
Complement-dependent cytotoxicity
Complement-dependent cytotoxicity (CDC) is a function of the complement system.
Complement-dependent cytotoxicity and Monoclonal antibody · Complement-dependent cytotoxicity and Ofatumumab ·
Multiple sclerosis
Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged.
Monoclonal antibody and Multiple sclerosis · Multiple sclerosis and Ofatumumab ·
Rheumatoid arthritis
Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints.
Monoclonal antibody and Rheumatoid arthritis · Ofatumumab and Rheumatoid arthritis ·
Rituximab
Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer.
Monoclonal antibody and Rituximab · Ofatumumab and Rituximab ·
The list above answers the following questions
- What Monoclonal antibody and Ofatumumab have in common
- What are the similarities between Monoclonal antibody and Ofatumumab
Monoclonal antibody and Ofatumumab Comparison
Monoclonal antibody has 177 relations, while Ofatumumab has 29. As they have in common 8, the Jaccard index is 3.88% = 8 / (177 + 29).
References
This article shows the relationship between Monoclonal antibody and Ofatumumab. To access each article from which the information was extracted, please visit: